Paclitaxel poliglumex (PPX)/carboplatin vs paclitaxel/carboplatin for the treatment of PS2 patients with chemotherapy-naive advanced non-small cell lung cancer (NSCLC): A phase III study.

被引：0
|
作者：
Langer, CJ
Socinski, MA
Ross, H
O'Byrne, KJ
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Oregon Clin, Portland, OR USA
[4] St James Hosp, Dublin 8, Ireland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1095S / 1095S
页数：1
相关论文
共 50 条
  • [41] Phase II study of carboplatin and weekly paclitaxel combination chemotherapy in advanced non-small-cell lung cancer(NSCLC)
    Kisohara, Akira
    Takahashi, Noriaki
    Tsujino, Ichirou
    Sato, Maki
    Horie, Takashi
    ANNALS OF ONCOLOGY, 2004, 15 : 180 - 180
  • [42] A randomized phase II study of sequential carboplatin/paclitaxel (CP) and gefitinib (G) in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC): Preliminary results.
    Nokihara, H.
    Ohe, Y.
    Kawaishi, M.
    Kato, T.
    Yamamoto, N.
    Sekine, I.
    Kunitoh, H.
    Saijo, N.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 388S - 388S
  • [43] A phase II study of gefitinib (G) versus carboplatin and gemcitabine (CG) in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC) and ECOG performance status (PS) 2
    Agarwal, S.
    Hirsh, V.
    Agulnik, J. S.
    Cohen, V.
    Mihalcioiu, C. L.
    Whittom, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Soejima, Kenzo
    Naoki, Katsuhiko
    Ishioka, Kota
    Nakamura, Morio
    Nakatani, Michie
    Kawada, Ichiro
    Watanabe, Hideo
    Nakachi, Ichiro
    Yasuda, Hiroyuki
    Satomi, Ryosuke
    Nakayama, Sohei
    Yoda, Satoshi
    Ikemura, Sinnosuke
    Terai, Hideki
    Sato, Takashi
    Ohgino, Keiko
    Arai, Daisuke
    Tani, Tetsuo
    Kuroda, Aoi
    Nishino, Makoto
    Betsuyaku, Tomoko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 513 - 519
  • [45] Phase lb extension study of eribulin in combination with carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer (NSCLC)
    Raftopoulos, H.
    Aisner, J.
    Kumar, K.
    Goel, S.
    Dittrich, C.
    Jain, M.
    Gopalakrishna, P.
    Salazar, P.
    Jones, B.
    Petrylak, D.
    ONKOLOGIE, 2013, 36 : 29 - 29
  • [46] Meloxicam in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer
    Takahashi, T
    Ueda, S
    Kogure, Y
    Ebisawa, M
    Asai, G
    Yamamoto, N
    LUNG CANCER, 2005, 49 : S271 - S271
  • [47] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Kenzo Soejima
    Katsuhiko Naoki
    Kota Ishioka
    Morio Nakamura
    Michie Nakatani
    Ichiro Kawada
    Hideo Watanabe
    Ichiro Nakachi
    Hiroyuki Yasuda
    Ryosuke Satomi
    Sohei Nakayama
    Satoshi Yoda
    Sinnosuke Ikemura
    Hideki Terai
    Takashi Sato
    Keiko Ohgino
    Daisuke Arai
    Tetsuo Tani
    Aoi Kuroda
    Makoto Nishino
    Tomoko Betsuyaku
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 513 - 519
  • [48] Phase I study of biweekly paclitaxel and carboplatin for frail patients with advanced non-small cell lung cancer
    Yanagitani, Noriko
    Tsuchiya, Satoshi
    Kaira, Kyoichi
    Sunaga, Noriaki
    Tsuchiya, Yukiko
    Sato, Koji
    Watanabe, Satoru
    Nomura, Shiro
    Sakai, Shuzo
    Saito, Ryusei
    Mori, Masatomo
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (05): : 487 - 491
  • [49] PIONEER: A phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2
    Albain, Kathy S.
    Belani, Chandra P.
    Bonomi, Philip
    O'Byrne, Kenneth J.
    Schiller, Joan H.
    Socinski, Mark
    CLINICAL LUNG CANCER, 2006, 7 (06) : 417 - 419
  • [50] Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naive non-small cell lung cancer in a clinically selected population excluding patients with nonsmoking adenocarcinoma or mutated EGFR
    Choi, Yoon Ji
    Lee, Dae Ho
    Choi, Chang Min
    Lee, Jung Shin
    Lee, Seung Jin
    Ahn, Jin-Hee
    Kim, Sang-We
    BMC CANCER, 2015, 15
12345